Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease

被引:8
|
作者
Rahimpour, Zahra [1 ]
Hoseini, Rastegar [1 ]
Behpour, Nasser [1 ]
机构
[1] Razi Univ, Fac Sport Sci, Dept Exercise Physiol, Kermanshah, Iran
关键词
NAFLD; Exercise; Vitamin D; Liver enzymes; Lipid profile; INSULIN-RESISTANCE; MUSCLE DAMAGE; MITOCHONDRIAL; EXPRESSION; CALCIUM; OBESITY;
D O I
10.1186/s12876-022-02457-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Eccentric exhaustive exercise (EEE) training has been known as a promising training modality to enhance performance and stimulate adaptation in healthy individuals or patients that might also cause abnormal liver enzymes and lipid profiles. Vitamin D (Vit D) supplementation is believed to improve the condition of Non-Alcoholic Fatty Liver Disease (NAFLD) patients. However, there is limited evidence on the effect of Vit D supplementation on the EEE-induced alterations. This study aimed to investigate the effect of short-term supplementation of Vit D on the liver enzymes and lipid profile alterations following EEE in overweight women with NAFLD. Methods In this clinical trial, 22 overweight women with NAFLD were randomly divided into experimental and control (n = 11 in each). The experimental group consumed 2000 IU of Vit D per day for six weeks; the control group consumed a lactose placebo daily with the same color, shape, and warmth percentage. Two treadmill EEE sessions were performed before and after the six-week Vit D supplementation. Blood was taken from the antecubital vein to measure the liver enzymes, lipid profile, and Vit D at four stages: Pre 1(before the first EEE session), Post 1(after the first EEE session), Pre 2 (before the second EEE session), and Post 2 (after the second EEE session). Results The results indicate that Vit D supplementation significantly reduced Bodyweight (BW; P = 0.047), Body Mass Index (BMI; P = 0.044), Body Fat Percentage (BFP; P = 0.001), and Waist Hip Ratio (WHR; P = 0.001) in the experimental group. Additionally, the results showed increased liver enzymes (ALT, AST, and GGT) and lipid profile (TC, TG, and LDL) following EEE. While the HDL levels decreased significantly after EEE. Compared with control, the results of the independent t-test showed significantly lower ALT (P = 0.001; P = 0.001), AST (P = 0.001; P = 0.001), and GGT (P = 0.001; P = 0.001); while significantly higher Vit D (P = 0.001, P = 0.001) in the experimental in both Pre 2 and Post 2; receptively. Also, significantly lower TC (P = 0.001; P = 0.001), TG (P = 0.048; P = 0.001), and LDL (P = 0.001; P = 0.001); while significantly higher HDL (P = 0.001, P = 0.001) were observed in the experimental group compared to the control in both Pre 2 and Post 2; receptively. Conclusions Vit D supplementation reduces the liver enzymes and improves lipid profile alterations following EEE in overweight women with NAFLD. Thus, Vit D supplementation can be considered a functional supplement to improve the EEE-induced alteration. Trial registration: The trial was in the Iranian Clinical Trial Registration Center under the (IRCT20201130049538N1) on 05/07/2021.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Effect of Endurance Exercise on Non-Alcoholic Fatty Liver Disease
    Sullivan, Shelby
    Kirk, Erik P.
    Patterson, Bruce
    Klein, Samuel
    GASTROENTEROLOGY, 2011, 140 (05) : S700 - S700
  • [42] The benefits of exercise for patients with non-alcoholic fatty liver disease
    Keating, Shelley E.
    George, Jacob
    Johnson, Nathan A.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (10) : 1247 - 1250
  • [43] Non-alcoholic fatty liver disease and metabolic syndrome in overweight adolescents
    de Moraes, Leticia Fregona Hungria
    Fernandes, Vania de Fatima Tonetto
    Salustriano, Ingrid Kelly Marinho
    Reis, Giovana Belisario
    Neto, Guido de Paula Colares
    Figueiredo, Carolina Costa
    Masquio, Deborah Cristina Landi
    Evangelista, Nara Michelle de Araujo
    MUNDO DA SAUDE, 2024, 48
  • [44] INSULIN RESISTANCE, LIPID METABOLISM AND FATTY ACID PROFILE IN CHILDREN WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Janczyk, W.
    Wierzbicka, A.
    Socha, P.
    Neuhoff-Murawska, J.
    Lembas, A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E152 - E153
  • [45] Alterations of Central Liver Metabolism of Pediatric Patients with Non-Alcoholic Fatty Liver Disease
    Berndt, Nikolaus
    Hudert, Christian A.
    Eckstein, Johannes
    Loddenkemper, Christoph
    Henning, Stephan
    Bufler, Philip
    Meierhofer, David
    Sack, Ingolf
    Wiegand, Susanna
    Wallach, Iwona
    Holzhutter, Hermann-Georg
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [46] Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial
    Izadi, Fatemeh
    Farrokhzad, Amirhosein
    Tamizifar, Babak
    Tarrahi, Mohammad Javad
    Entezari, Mohammad Hassan
    PHYTOTHERAPY RESEARCH, 2021, 35 (01) : 477 - 485
  • [47] Non-alcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension
    Catena C.
    Cosma C.
    Camozzi V.
    Plebani M.
    Ermani M.
    Sechi L.A.
    Fallo F.
    High Blood Pressure & Cardiovascular Prevention, 2013, 20 (1) : 33 - 37
  • [48] SERUM VITAMIN D DEFICIENCY IN NON-ALCOHOLIC FATTY LIVER DISEASE; CHICKEN OR THE EGG?
    Jun, D. W.
    Saeed, W. K.
    Nam, H. H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S722 - S722
  • [49] Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial
    Ebrahimpour-Koujan, Soraiya
    Sohrabpour, Amir Ali
    Foroughi, Farshad
    Alvandi, Ehsan
    Esmaillzadeh, Ahmad
    TRIALS, 2019, 20 (1)
  • [50] Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial
    Soraiya Ebrahimpour-Koujan
    Amir Ali Sohrabpour
    Farshad Foroughi
    Ehsan Alvandi
    Ahmad Esmaillzadeh
    Trials, 20